Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: bupivacaine

« Back to Dashboard

Summary for Generic Name: bupivacaine

Tradenames:13
Patents:3
Applicants:8
NDAs:36
Drug Master File Entries: see list10
Suppliers: see list1

Pharmacology for Ingredient: bupivacaine

Ingredient-typeAmides
Drug ClassAmide Local Anesthetic
Physiological EffectLocal Anesthesia

Clinical Trials for: bupivacaine

2% Lidocaine Plus 0.5% Bupivacaine Versus 0.5% Bupivacaine in Brachial Block for Creation of Arteriovenous (AV) Fistula
Status: Recruiting Condition: Infraclavicular Brachial Plexus Block

Bupivacaine Pain Pumps to Decrease Mastectomy Post-Operative Pain
Status: Not yet recruiting Condition: Pain

ED50 and ED95 of Intrathecal Bupivacaine With or Without Epinephrine for Total Knee Replacement Arthroplasty
Status: Completed Condition: Spinal Anesthesia; Total Knee Replacement Arthroplasty

Plasma Concentrations of Bupivacaine After Peri-articular Injection in Total Knee Arthroplasty
Status: Completed Condition: Serum Bupivacaine Level; Periarticular Block; Total Knee Arthroplasty

Efficacy of Interscalene Brachial Plexus Block With Liposomal Bupivacaine for Arthroscopic Shoulder Surgery
Status: Recruiting Condition: Shoulder Pain; Rotator Cuff Tear

Efficacy of Single Injection Femoral Nerve Block With Liposomal Bupivacaine for Total Knee Arthroplasty
Status: Not yet recruiting Condition: Total Knee Arthroplasty

Analgesic Efficacy of Two Concentrations of Bupivacaine in Women in Labor
Status: Completed Condition: Obstetric Pain

Determination of the Effective Volume of 0.125% Bupivacaine-fentanyl 5mcg/mL in Labour Epidurals
Status: Completed Condition: Pain

Comparison of Standard and Minidose Spinal Anesthesia for Cesarean Section Operation Using Marcaine Spinal 0.5% Heavy
Status: Not yet recruiting Condition: Cesarean Section; Anesthesia, Spinal; Local Anaesthetics Causing Adverse Effects in Therapeutic Use

Liposomal Bupivacaine for Post Operative Pain After Knee Replacement Surgery
Status: Not yet recruiting Condition: Post-operative Pain

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira
MARCAINE HYDROCHLORIDE PRESERVATIVE FREE
bupivacaine hydrochloride
INJECTABLE;INJECTION016964Approved Prior to Jan 1, 1982RXYes<disabled><disabled>
Fresenius Kabi Usa
SENSORCAINE
bupivacaine hydrochloride
INJECTABLE;INJECTION070554May 21, 1986RXNo<disabled><disabled>
Fresenius Kabi Usa
SENSORCAINE
bupivacaine hydrochloride
INJECTABLE;INJECTION018304Approved Prior to Jan 1, 1982RXNo<disabled><disabled>
Fresenius Kabi Usa
SENSORCAINE
bupivacaine hydrochloride; epinephrine bitartrate
INJECTABLE;INJECTION070966Oct 13, 1987RXNo<disabled><disabled>
Pacira Pharms Inc
EXPAREL
bupivacaine
INJECTABLE, LIPOSOMAL;INJECTION022496Oct 28, 2011RXYes8,182,835<disabled>Y<disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc